Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (Weighted Average) (2016 - 2025)

Assembly Biosciences has reported Shares Outstanding (Weighted Average) over the past 11 years, most recently at $11.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $11.2 million for Q4 2025, up 86.71% from a year ago — trailing twelve months through Dec 2025 was $11.2 million (up 86.71% YoY), and the annual figure for FY2025 was $11.2 million, up 86.71%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $11.2 million at Assembly Biosciences, down from $12.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ASMB hit a ceiling of $48.4 million in Q3 2022 and a floor of $4.0 million in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $7.6 million (2025), compared with a mean of $20.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 91.17% in 2023 and later surged 99.74% in 2025.
  • Assembly Biosciences' Shares Outstanding (Weighted Average) stood at $43.3 million in 2021, then tumbled by 90.68% to $4.0 million in 2022, then grew by 13.47% to $4.6 million in 2023, then skyrocketed by 31.18% to $6.0 million in 2024, then skyrocketed by 86.71% to $11.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $11.2 million (Q4 2025), $12.7 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.